A Phase 1/2 Trial of X4P-001 as Single Agent and in Combination with Axitinib in Patients with Advanced Renal Cell Carcinoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1/2 Trial of X4P-001 as Single Agent and in Combination with Axitinib in Patients with Advanced Renal Cell Carcinoma

Type of Cancer
Genito-Urinary
Locations
Hackensack
Sponsor
X4 Pharmaceuticals
Protocol Number
X4P-001
Cancer Diagnosis
To Learn More Call
201-510-0910